These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12885732)

  • 1. Vascular brachytherapy boon or bust?
    Kereiakes DJ; Willerson JT
    Circulation; 2003 Jul; 108(4):389-90. PubMed ID: 12885732
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular radiation in a drug-eluting stent world: it's not over till it's over.
    Teirstein PS; King S
    Circulation; 2003 Jul; 108(4):384-5. PubMed ID: 12885730
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
    Waksman R; Weinberger J
    Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
    [No Abstract]   [Full Text] [Related]  

  • 4. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent in patients with diabetes mellitus.
    Finn AV; Gold HK
    Circulation; 2004 Sep; 110(12):e318-9; author reply e318-9. PubMed ID: 15381668
    [No Abstract]   [Full Text] [Related]  

  • 5. Brachytherapy: here today, gone tomorrow?
    Thomas MR
    Heart; 2005 Jun; 91 Suppl 3(Suppl 3):iii32-4. PubMed ID: 15919650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Past, present, and future of intracoronary brachytherapy].
    Angiolillo DJ; Sabaté M
    Ital Heart J Suppl; 2003 Oct; 4(10):794-806. PubMed ID: 14664291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint.
    Tripuraneni P
    Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-eluting stents: cost versus clinical benefit.
    Lemos PA; Serruys PW; Sousa JE
    Circulation; 2003 Jun; 107(24):3003-7. PubMed ID: 12821586
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-eluting stents: costs versus clinical benefit.
    O'Neill WW; Leon MB
    Circulation; 2003 Jun; 107(24):3008-11. PubMed ID: 12821587
    [No Abstract]   [Full Text] [Related]  

  • 10. The future of coronary artery radiation therapy--"the CART before the (unbridled) horse!". Point.
    Devlin PM
    Brachytherapy; 2003; 2(2):73-4. PubMed ID: 15062142
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of randomized trials of drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
    Boyden TF; Nallamothu BK; Moscucci M; Chan PS; Grossman PM; Tsai TT; Chetcuti SJ; Bates ER; Gurm HS
    Am J Cardiol; 2007 May; 99(10):1399-402. PubMed ID: 17493468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TOR of the cell cycle: Are there important implications for diabetics in the era of the drug-eluting stent?
    Carter AJ
    Catheter Cardiovasc Interv; 2004 Feb; 61(2):233-6. PubMed ID: 14755819
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic drug therapy for restenosis: "déjà vu all over again".
    Faxon DP
    Circulation; 2002 Oct; 106(18):2296-8. PubMed ID: 12403655
    [No Abstract]   [Full Text] [Related]  

  • 14. How to approach drug-eluting stent restenosis.
    Roy P; Waksman R
    Minerva Cardioangiol; 2006 Oct; 54(5):571-6. PubMed ID: 17019394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug-eluting stents and other anti-restenosis devices].
    Moreno R
    Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late stent thromboses a neglected problem? Indications of increased risk with drug-eluting stents].
    Stenestrand U
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2838-9. PubMed ID: 17128915
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
    Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
    J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.
    Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R
    Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents: the panacea for restenosis?
    Lim MC
    Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.